Ask AI
OptiTROP Breast05
OptiTROP-Breast05: Phase II Trial of Sacituzumab Tirumotecan (Sac-TMT) in the 1L Treatment of Unresectable Locally Advanced/Metastatic TNBC

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025